ACCESS
EU-JAMRAI aims to provide substantial assistance to Member States (MS) in the development and periodic updating of their National Action Plans (NAPs) on Antimicrobial Resistance (AMR). By offering direct and significant support, the initiative seeks to enhance the capacity of MS to effectively tackle AMR within their healthcare systems. Secondly, EU-JAMRAI endeavors to bolster the responsiveness and coordination of health systems across the Union, thereby safeguarding individuals from the threat of AMR. Through improved collaboration and streamlined efforts, the initiative aims to fortify the resilience of healthcare systems against the proliferation of drug-resistant infections.
One of the main objectives of EU-JAMRAI in this field is to improve access to selected AMR-related products both for human and veterinarian use:
High-priority products
EU-JAMRAI is working to identify products with vulnerable supply per country to drive its actions on evidence-based reports.
Click on each country on the map to find out about the high-priority products.
France
Content is not available
Spain
Phenoximethylpenicillin benzatine (Human)
Cefadroxil (Human)
Aztreonam (Human)
Amikacin (Human)
Trimetoprim and Sulfamethoxazole (Human)
Oxytetracycline (Veterinary)
*This list is not complete and more products will be added soon.
Belgium
Content is not available
Bulgaria
Eravacycline (human)
Benzylpenicillin (human)
Phenoxymethylpenicillin (human)
Ceftaroline (human pediatric only)
Erythromycin (human)
Tobramycin (human)
Nitrofurantoin (human)
Fosfomycin (human)
Daptomycin (human)
Amphotericin B “liposomal” (human)
Denmark
Content is not available
Finland
Content is not available
Iceland
Content is not available
Italy
Content is not available
Netherlands
Content is not available
Norway
Benzylpenicillin (human and veterinary)
Dicloxacillin (human)
Doxycycline (human)
Flucloxacillin (human pediatric only)
Gentamicin (human)
Phenoxymethylpenicillin (human)
Pivmecillinam (human)
Tuberculosis antibiotics (human)
Vaccines for salmon (veterinary)
Poland
Content is not available
Slovenia
Content is not available
Sweden
Amoxicillin (human)
Temocillin (human)
Phenoxymethylpenicillin (human)
Ceftibuten (human)
Trimethoprim, sulfamethoxazole (human)
Colistin (human)
Pivmecillinam (human)
Rifampicin (human)
Procaine benzylpenicillin (veterinary)
Trimethoprim, sulfadiazine (veterinary)
Malta
Amoxicillin (Human)
Temocillin (Human)
Cefalexin (Human)
Amikacin (Human)
Cefazolin (Human)
Aztreonam (Human)
Co-trimoxazole (Human)
Clindamycin (Human)
Fosfomycin (Human)
Targeted interventions
Demand barriers
Supply barriers
